Companies are in the process of testing a device that will replace lung volume reduction surgery for patients with emphysema and repair heart valves by going through the skin.
Volcano Therapeutics, a maker of IVUS machines, is testing a new version that uses sophisticated software to quickly determine plaque composition and volume.
As noted previously, the weekly on-balance volume (OBV) did form a negative divergence at the recent highs (see circle) and is now testing its weighted moving average.